The LIR family (also known as the immunoglobulin-like transcripts (ILTs), monocyte/macrophage immunoglobulin-like receptors and CD85) comprises a set of immunoreceptors expressed on the surface of lymphoid and myeloid cells 1,2 . The LIRs, which are related to natural killer cell killer immunoglobulin-like receptors (KIRs) and the immunoglobulin A (IgA) receptor FcαRI, are highly similar to one another, sharing 63-84% amino acid identity in their extracellular regions. All except LIR-4 are type 1 transmembrane proteins, containing either two or four immunoglobulin superfamily domains in their extracellular regions. One subset of cell surface LIR molecules (LIR-1, LIR-2, LIR-3, LIR-5 and LIR-8) transmits inhibitory signals through intracellular tyrosine-based inhibitory motifs, whereas another group (LIR-6, LIR-7, ILT7, ILT8, ILT10 and ILT11) transmits activatory signals by associating with signaling adaptor molecules 1,2 .
LIR-1 of a broad range of MHC class I molecules in a peptideindependent way 1,2 .
The crystal structure shows a 1:1 LIR-1:HLA-A2 stoichiometry, as predicted by analytical ultracentrifugation studies 8 , with no evidence for LIR-1 or HLA-A2 dimers or oligomers. The LIR-1 N-terminal domain and N-terminal residues are oriented toward the membraneproximal portion of the HLA-A2 ectodomain (Fig. 1a) , which is most consistent with a trans interaction involving recognition of an MHC class I molecule on a target cell by a LIR-1 protein on an opposing effector cell. A cis interaction between LIR-1 and an MHC class I molecule on the same cell surface would require LIR-1 domains 3 and 4 and the connecting region of LIR-1 to nearly reverse directions compared with the orientation of LIR-1 D1D2, resulting in a horseshoe-like arrangement of the four LIR-1 domains that is inconsistent with sedimentation velocity data 8 and conservation of residues involved in interactions at the interface between D1 and D2 in the D2-D4 region 8 .
Conformational changes in LIR-1
Although the structures of free HLA-A2 and HLA-A2 in a complex are not very different (r.m.s. deviation on all Cα atoms of 0.91 Å), comparison of the structures of free and bound LIR-1 D1D2 showed a change in the D1D2 interdomain angle (Fig. 1c) . The angles between the long axes of the LIR-1 D1 and D2 domains were calculated as 84°, 85°and 90°in crystal structures of free LIR-1 D1D2 (ref. 11) . When in a complex with HLA-A2, the LIR-1 D1D2 angle increases to 100°, indicating substantial flexibility of the D1D2 angle in the unbound state. Although crystal contacts could be involved in this interdomain shift, the interdomain angle in the co-crystal structure allows optimal contacts with both the α3 and β 2 M domains of HLA-A2, and is therefore likely to reflect stabilization of a particular LIR-1 hinge region conformation that facilitates binding. A structurally analogous increase of similar size (∼10°) in the interdomain angle of KIR2DL1 noted after binding to HLA-Cw4 (Fig. 1c) was also attributed to optimization of domain orientation for ligand binding, and was not considered relevant to inhibitory signal initiation 14 .
LIR-1 binding involves two surfaces on HLA-A2
There are two distinct contact areas in the LIR-1−HLA-A2 interface ( Fig. 2) : the A′CC′FG face at the tip of LIR-1 D1 contacts the HLA-A2 α3 domain (with the exception of D1 residue Lys42, which contacts β 2 M residue Asp96), and the LIR-1 D1-D2 interdomain hinge region contacts the β 2 M domain. The contacting residues on the α3 domain are located at the end of strand A and in the A-B loop (residues 193-200) and the E strand (residue 248; Fig. 3a) . Contact regions on β 2 M are located toward the N-terminus (residues 1-4), in the F-G strand loop (residues 86-89) and in the G strand itself (residues 91-94, 96 and 99). The size of the LIR-1−HLA-A2 interface (∼1,700 Å 2 total buried solvent-accessible surface area) is marginally larger than those of KIR-MHC interfaces (∼1,500Å 2 ; ref. 10 ) and similar to those of TCR-MHC complexes (1,700-1,900 Å 2 ; ref. 13) . Of the LIR-1 binding surface that is buried after complex formation (835 Å 2 ), about 70% is involved in contacts with 14 β 2 M residues, with the remainder contacting 6 α3 domain residues ( Table 2 and Fig. 2 ). This relative dominance of β 2 M is unprecedented among HLA-binding immunoreceptors, including KIRs 10 , TCRs 13 and CD8 (ref. 15) , and is partly responsible for the broad recognition properties of LIR-1.
Previous studies have suggested that both α3 and β 2 M interaction surfaces in the crystal structure contribute energetically to MHC class I and UL18 recognition. Domain-swapping experiments have shown that LIR-1 D1-D4 binding was abolished when the α3 domain of HFE was incorporated into UL18 and MHC class I proteins 8 , consistent with the idea that specific LIR-1 D1 contacts with α3 domain residues in the crystal structure are energetically important. Moreover, a proteolytic fragment of LIR-1 D1D2, (residues 1-99, referred to as D1, but containing residues 97-99 of the interdomain hinge region) bound UL18 and HLA-Cw0702 with only one-quarter to one-third the affinity that of D1D2 (ref. 8) . The binding of the D1 fragment alone can now be understood as an interaction with the MHC class I α3 and β 2 M domains, with the reduction in affinity being caused by the absence of one or more of the D2 residues in the interdomain hinge region (residues 100, 127, 184 and 187), which make contacts to β 2 M in the case of D1D2.
A highly conserved LIR-1 binding site on MHC class I molecules
To further rationalize the broad recognition of MHC class I by LIR-1, we examined the sequences of classical and nonclassical MHC class I molecules, as well as MHC class I-like molecules that do not bind LIR-1 (FcRn, HFE and ZAG) 8 from the LIR-1-HLA-A2 structure as making contacts with LIR-1 (α3 residues 193-196, 198 and 248) . With the exception of Ala193, these all involve amino acid side-chain-specific interactions. In all classical and nonclassical MHC class I molecules examined, residues Glu198 and Val248 are conserved, residue 193 is either a proline or an alanine, and residue 194 is an uncharged hydrophobic amino acid (Fig. 3a) . In addition, residues 195-197 are conserved in HLA-A, HLA-B, HLA-C, HLA-E and HLA-F. The most divergent sequence is that of HLA-G, which contains two amino acid changes, at positions 195 (Ser to Phe) and 197 (His to Tyr). The positions and nonconservative nature of these changes indicate that they could affect interaction with HLA-G, consistent with the slightly higher (three-to fourfold) affinities of LIR-1 and LIR-2 for HLA-G relative to other MHC class I molecules 9 . In contrast to most MHC class I molecules, FcRn, HFE and ZAG each contain four to six amino acid changes, of which three to four are nonconservative, from the MHC class I consensus sequence in the contact residues. The comparison described above indicates that in addition to residues on β 2 M, LIR-1 recognizes a sequence motif on the α3 domain that is essentially restricted to classical and nonclassical MHC class I molecules, and that α3 domain contacts provide essential energetic contributions to binding energy. Subtle differences in the β 2 M and α3 domain orientation could also affect LIR-1 binding, although the relative positions of the β 2 M and α3 domains are mostly conserved in available structures of MHC class I proteins, and of the MHC homologs FcRn and HFE.
Of the six LIR-1 amino acids that contact the HLA α3 domain, four (Arg36, Tyr38, Arg39 and Lys41) are conserved in LIR-2 ( Fig. 3b) , whereas alternative uncharged polar amino acids are substituted at positions 43 (Thr to Ser) and 76 (Tyr to Gln). Superposition of the D1 domain of each receptor indicates these residues occupy similar positions in LIR-1 and LIR-2. Conservation of interactions involving these residues is consistent with the similar affinities and broad specificity of both receptors for MHC class I molecules.
DISCUSSION
The LIR-1−HLA-A2 structure can help in the interpretation of previous studies suggesting that LIR-1 uses a common binding interaction to recognize UL18 and MHC class I molecules 8 . Domain-swapping experiments have indicated that LIR-1 D1 and the MHC class I and UL18 α3 domains are interaction sites 8 , as now verified for LIR-1 recognition of HLA-A2. Mutagenesis of LIR-1 identified four D1 residues (Tyr38 and one or more of Tyr76, Asp80 and Arg84) that affected binding to UL18 when substituted 11 . Tyr38 and Tyr76 are involved in specific contacts with HLA-A2 α3 domain residues in the region of positions [193] [194] [195] [196] (Table 2a) . Together with the fact that contacts between LIR-1 and β 2 M are likely to be conserved in the viral 16 , a similar binding mode would favor recognition in trans, such as UL18 on an human cytomegalovirus-infected cell engaging LIR-1 on an effector cell, or alternatively UL18−LIR-1 interaction between opposing membranes in intracellular compartments. Despite the similarities in the binding of LIR-1 to UL18 and to MHC class I molecules, UL18 achieves an affinity in the nanomolar range, over 1,000-fold higher than that of LIR-1−MHC class I interactions 8 . When the 13 potential N-linked glycosylation sites of UL18 (ref. 5) are mapped onto the D1D2−HLA-A2 structure, the predicted LIR-1 binding site is one of the few contiguous surfaces that does not contain a potential glycosylation site (Fig. 4a) , consistent with the observation that the nature of the carbohydrate attached to UL18 (complex or high-mannose carbohydrates) does not affect binding to LIR-1 (ref. 8) . A more likely explanation for increased affinity for the viral homolog is a more favorable interaction of LIR-1 with amino acids on the α3 domain of UL18 than the comparable region of MHC class I proteins. Comparison of the UL18 sequence in the region analogous to the LIR-1-contacting residues in HLA-A2 (Fig. 3a) shows conservation 916 VOLUME 4 NUMBER 9 SEPTEMBER 2003 NATURE IMMUNOLOGY Thr43 Ala193
Tyr76 Asp196
Glu68 Lys94
Gly97 Ser88
Ala98 Leu87, Ser88
Asp184 Lys91
Leu187 Ser88
Amino acid contacts (≤4.0 Å) between LIR-1 D1 and HLA-A2 α3 domain (top); LIR-1 D1 and β 2 M (middle); and LIR-1 D2 and β 2 M (bottom).
of Asp196, a residue also conserved throughout classical and nonclassical MHC class I molecules, but substituted nonconservatively in FcRn, HFE and ZAG (Fig. 3a) . In HLA-A2, this residue makes contacts with LIR-1 Tyr76, a residue that has been linked to the interaction with UL18 (ref. 11). The remaining five residues within the UL18 counterpart of the LIR-1 contact region on the HLA-A2 α3 domain (residues 193-196, 198 and 248) differ between the UL18 and MHC class I sequences. Two substitutions are conservative (Ser to Asn at 195; Val to Ala at 248), whereas three are nonconservative (Pro to Asn at 193; Ile to Gln at 194; Glu to Arg at 198). These differences, perhaps together with an optimal orientation of the UL18 α3 and β 2 M domains, may contribute to the increased affinity of UL18 for LIR-1. UL18 is highly selective for LIR-1, binding over 3,000-fold more strongly then to LIR-2 (ref.11). The crystal structure of LIR-2 D1D2 identified conformational alterations relative to LIR-1 in both established elements of the UL18 binding site: an alternative rotamer conformation of Tyr38, and an 11-Å shift in the loop of residues 76-84 (ref. 17) . When the structures of LIR-1 D1 and LIR-2 D1 not in complexes are superimposed onto LIR-1 D1 in the LIR-1−HLA-A2 complex structure (Fig. 4b and Methods), the LIR-1 loop of residues 76-84 (residues 78-83 are disordered in the LIR-1−HLA-A2 structure) is oriented toward the α3 domain. However, the main chain conformation of the LIR-2 loop (which contains a one-residue deletion and two glycine-to-nonglycine substitutions relative to LIR-1) is shifted 11 Å away from the contact interface, preventing interaction of residues 79-82 with the MHC class I (here representing UL18; Fig. 4b ). In addition, the three residues in the D1 loop of residues 76-84 that have been linked to UL18−LIR-1 binding (Tyr76, Asp80 and Arg84) are substituted nonconservatively in LIR-2 (to Gln76, Arg80 and Trp83) 11 . Consequently, even assuming considerable flexibility in this region of LIR-2, UL18 may interact preferentially with LIR-1 side chains at these positions, as indicated by the demonstration that a LIR-2 D1D2 protein containing LIR-1 residues at these positions bound UL18 ∼10-fold more tightly than did wild-type LIR-2 D1D2 (ref. 11). Differences in the LIR-2 region of the loop of residues 76-84 may also provide an explanation for the slightly higher (three-to fourfold) affinities for LIR-1 binding to HLA-A, HLA-B, and HLA-C molecules compared with that for LIR-2 (ref. 9) .
Comparison of the LIR-1 residues that interact with the HLA-A2 β 2 M domain with other LIR receptors separates the LIR family members into two groups (Fig. 3b) . Group 1 members, which include the inhibitory receptors LIR-1 and LIR-2, the soluble receptor LIR-4, and the activatory receptors LIR-6a, LIR-6b and LIR-7, show high conservation (≥10 of 13) of these residues. Group 2 members, which comprise LIR-3, LIR-5 and LIR-8 (all of which are likely to transmit inhibitory signals), and ILT7, ILT8 and ILT11 (not represented in the LIR family), show poor conservation (≤4 of 13) in which >85% of the changes are either nonconservative substitutions or deletions. Similar results are obtained by a comparison of the HLA-A2 α3 domaincontacting residues conserved or substituted conservatively between LIR-1 and LIR-2 (residues 36, 38, 39, 41 and 43). Thus, the ligands of other group 1 members are likely to include MHC class I or MHC class I-like molecules noncovalently associated with β 2 M, as already demonstrated for LIR-2 and LIR-6 (refs. 1,2,18). In contrast, group 2 members LIR-3, LIR-5 and LIR-8 seem unlikely to engage MHC class I proteins using a binding mode similar to that of LIR-1, and most probably engage a different set of ligands.
Specificity for a broad range of MHC class I molecules distinguishes LIR-1 and LIR-2 from KIR ligand recognition, and indicates that the strength of LIR-1 and LIR-2 signals may reflect the overall expression of MHC class I on the target cell. How LIR-HLA binding leads to signal initiation, and how such signals integrate with activatory signals propagated at the cell surface, are key questions. No evidence of ligandinduced oligomerization is apparent from an inspection of crystal contacts, and alterations in the D1D2 angle may reflect adoption of an ideal orientation for binding rather than a signaling mechanism. Alternatively, signaling may result from the LIR-1−MHC complexes' cosegregating with activatory ligand-receptor interactions in areas of close contact during cell-cell interaction, thereby recruiting phosphatases to an otherwise highly activatory environment 19 . Indeed, LIR-1 and TCR colocalize at the 'immunological synapse' formed between T cells and APCs expressing TCR and LIR-1 ligands 20 . The lengths of protein-protein interactions determining the spacing of the opposing cell membranes are essential parameters in such signaling models 19 . Notably, the length of the LIR-1−A2 interaction derived from the crystal structure and a homology model of the LIR-1 D3 and D4 domains 11 indicate that cosegregation with TCR-MHC or KIR-MHC complexes in such 'close-contact zones' at the immunological synapse is likely (Fig. 5) .
The LIR-1 D1D2−HLA-A2 structure shows no contacts with or conformational changes in the HLA-A2 α1-α2 peptide-binding platform; thus, simultaneous interaction of LIR-1 D1D2 and either a KIR or a TCR with a single MHC class I molecule should also be possible in principle. Either might be physiologically relevant, as LIR-1 is coexpressed at the cell surface with TCRs on MHC class I-restricted CD8 + T cells and with KIRs on subsets of natural killer cells 21 . In contrast, simultaneous binding of LIR-1 and the T-cell coreceptors CD8αα or CD8 αβ, which contact MHC class I α3 and β 2 M domains 15 , would not be possible. Although the CD8αα and LIR-1 binding sites on MHC class I are mainly nonoverlapping, steric effects would exclude binding of both LIR-1 and CD8 to the same MHC class I molecule (Fig. 5) , as confirmed by binding studies 9 . Thus, LIR-1 may inhibit activation signals on MHC class I-restricted T cells by competing with CD8 for binding to MHC class I complexes engaged by the TCR, with the dual effect of preventing stimulatory signals transmitted by CD8 and of recruiting SHP-1 phosphatase to the vicinity of the TCR, thereby decreasing the half-lives of phosphorylated signaling components. In this way, LIR-1 could potentially act as a potent 'negative coreceptor' on MHC class I-restricted T cells or natural killer cells expressing LIR-1.
LIR proteins are encoded within the leukocyte receptor cluster, a region of human chromosome 19 that also includes the genes for KIRs and the IgA receptor FcαRI (ref. 22) . These genes have probably diverged from a common ancestor, resulting in receptor families that interact in different ways with structurally diverse ligands. LIR-1 and KIRs use the D1-D2 interdomain hinge to interact with MHC class I molecules, but only LIR-1 uses an additional binding surface located toward the membrane-distal tip of D1 (Fig. 6) . FcαRI also uses the tip of its D1 domain to bind to the Fc portion of IgA, but does not use the D1-D2 interdomain hinge region used by LIR-1, KIRs and other Fc receptors encoded outside of the leukocyte receptor cluster, such as the FcγR and FcεRI proteins 23 (Fig. 6) .
The use of two binding surfaces on LIR-1 establishes a molecular link to the recognition surfaces used by KIRs and FcαRI in ligand binding, and raises questions as to the nature of the evolutionary relationships between these immunoreceptors. Based on gene structure and the existence of orthologous murine receptors (the paired immunoglobulinlike receptors 24 ), it seems likely LIRs evolved before KIRs. The homology of chicken immunoglobulin-like receptors to LIRs and paired immunoglobulin-like receptors supports the idea of the existence of a common ancestor pre-dating the separation of bird and mammalian lineages 25 . In contrast, several features of the KIRs, including the lack of rodent orthologs, high similarity between different KIR loci and differences between chimpanzee and human KIR sequences, indicate a more rapid and recent evolution, restricted to primates [25] [26] [27] . In common with KIRs, FcαRI lacks a murine ortholog, favoring the idea that it originated more recently than the LIRs. These arguments, in combination with the current structural data, are consistent with the recent proposal that KIR and FcαRI genes evolved from recombinations, duplications and shuffling events involving ancestral LIR genes 25 . The presence of two (rather than one) binding surfaces on LIR-1 may therefore be characteristic of a more ancient receptor, which subsequently diverged into KIRs, preserving the use of the D1-D2 interface region, FcαRI, which uses a more extensive D1 membrane-distal binding site, and LIR-1, preserving both interaction sites.
METHODS
Recombinant protein production. The HLA-A2 complex (comprising residues 1-276 of the mature A2 heavy chain, noncovalently associated with β 2 M and a nonamer peptide (ILKEPVHGV) derived from human immunodeficiency virus 1 Pol) and LIR-1 D1D2 (residues 1-198 of the mature protein) were produced using existing methods involving expression in Escherichia coli and dilution refolding 28 . Renatured LIR-1 and HLA-A2 complex were concentrated separately, and were purified by size-exclusion chromatography using a Superdex 75 column. The purified proteins were concentrated and quantified by absorption measurements at 280 nm. Extinction coefficients (280 nm) of 66,150 M -1 cm -1 (HLA-A2 complex) and 48,275 M -1 cm -1 (LIR-1) were calculated using amino acid analysis and as described 29 .
Crystallization, data collection and processing. Hanging-drop crystallization trials were done using a 1:1 stoichiometric mixture of purified LIR-1 and HLA-A2 complex (14.5 mg/ml total protein concentration). Microcrystals were initially obtained over a period of 3 weeks in 0.2 M sodium acetate, 0.1 M Tris, pH 8.5, and 30% weight/volume polyethylene glycol 4000. Subsequent additive and detergent screens resulted in growth of optimized crystals in 0.2 M sodium acetate, 0.1 M Tris, pH 8.5, 30% weight/volume polyethylene glycol 4000, 20 mM L-cysteine and 1.8 mM Triton X-100. Crystals were transferred to a collection buffer consisting of 0.2 M sodium acetate, 0.1 M Tris, pH 8.5, and 31% weight/volume polyethylene glycol 4000 supplemented with increasing concentrations of ispropanol to a final concentration of 7.5%. Data were collected from cryopreserved crystals at a temperature of 100 K at 0.992 Å at beamline 0.3 at the Advanced Light Source, Berkeley National Laboratory (Berkeley, California). Crystals belonged to the space group P3 1 21, with unit cell dimensions a = b = 113.74 Å, and c = 89.46 Å, and contain one HLA-A2−LIR-1 complex per asymmetric unit. Data were auto-indexed and integrated using the program DENZO, and scaled using the program SCALEPACK 30 .
Structure solution, refinement and analysis. The structure was determined by molecular replacement using the program AmoRe 31 and the coordinates of LIR-1 D1D2 and HLA-A2. Unambiguous solutions were found in the crossrotation and translation functions for HLA-A2 and LIR-1 (R cryst = 41%; R free = 43%) for data between 20 Å and 4.0 Å. After four-domain rigid-body refinement with REFMAC5, as implemented in the CCP4 program suite 32 , rebuilding was accomplished with the program O (ref. 33) using 2F o -F c annealed omit maps (Fig. 1b) , alternating with reciprocal space refinement in the crystallography and nuclear magnetic resonance system (CNS) 34 . Final rounds of simulated annealing refinement and subsequently B factor refinement using grouped temperature factors in CNS 34 resulted in a final R cryst of 22.2% (R free = 31.0%) for all data between 20 Å and 3.4 Å ( Table 1 and Supplementary Fig. 1 online) . The HLA-A2−LIR-1 complex model consists of residues 1-276 of the HLA-A2 heavy chain; peptide residues 1-9; β 2 M residues 1-16, 21-73 and 76-99; and LIR-1 residues 4-27, 32-77, 84-138 and 141-198. The side chains of residues 17, 82 and 268 of HLA-A2; 41 and 94 of β 2 M; and 33, 34, 52, 53, 56, 57, 84, 86 and 87 of LIR-1 were disordered and modeled as alanine residues. Disulfide bonds are found between LIR-1 residues 26 and 75, 122 and 174, and 134 and 144; HLA-A2 residues 101 and 164, and 203 and 259; and β 2 M residues 25 and 80. For analysis of interdomain angles, contacts and buried surface areas, D1 is defined as residues 1-98 and D2 is defined as residues 99-198. Interdomain contact residues were identified using the program CONTACT 32 , and were defined as residues containing an atom of ≤4.0 Å of the partner domain. Buried surface areas were calculated using SURFACE 32 with a 1.4-Å probe radius. Interdomain angles were calculated using the program Dom_angle 35 , which determines the angle between the long axes of adjacent domains that are approximated by
